Literature DB >> 35590011

Quality of life and secondary outcomes for open versus robot-assisted radical cystectomy: a double-blinded, randomised feasibility trial.

Maja Vejlgaard1,2, Sophia Liff Maibom3,4, Ulla Nordström Joensen3,4, Peter Ole Thind5,4, Malene Rohrsted5,4, Eske Kvanner Aasvang6,4, Henrik Kehlet7,4, Martin Andreas Røder3,4.   

Abstract

PURPOSE: This study aims to examine quality of life (QoL) before and after radical cystectomy (RC) and compare robot-assisted laparoscopy with intracorporeal urinary diversion (iRARC) to open radical cystectomy (ORC).
METHODS: This study is a predefined secondary analysis of a single-centre, double-blinded, randomised feasibility trial. Fifty patients were randomly assigned to iRARC with ileal conduit (n = 25) or ORC with ileal conduit (n = 25). Patients were followed 90 days postoperatively. The primary outcome was patient-reported QoL using the EORTC Cancer-30 and muscle-invasive bladder cancer BLM-30 QoL questionnaires before and after RC. Differences between randomisation arms as well as changes over time were evaluated. Secondary outcomes included 30- and 90 day complication rates, 90 day readmission rates, and 90 day days-alive-and-out-of-hospital and their relationship to QoL.
RESULTS: All patients underwent the allocated treatment. We found no difference in QoL, complication rates, readmission rates, and days-alive-and-out-of-hospital between randomisation arms. An overall improvement in QoL was found in the following domains: future perspectives, emotional functioning, and social functioning. Sexual functioning worsened postoperatively. There was no association between having experienced a major complication or lengthy hospitalisation and worse postoperative QoL.
CONCLUSION: The QoL does not appear to depend on surgical technique. Apart from sexual functioning, patients report stable or improved QoL within the first 90 postoperative days.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bladder cancer; Patient-reported outcomes; Quality of life; Radical cystectomy; Randomised controlled trial; Robotic surgery

Mesh:

Year:  2022        PMID: 35590011     DOI: 10.1007/s00345-022-04029-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  22 in total

1.  Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations.

Authors:  Dionysios Mitropoulos; Walter Artibani; Markus Graefen; Mesut Remzi; Morgan Rouprêt; Michael Truss
Journal:  Eur Urol       Date:  2011-10-29       Impact factor: 20.096

2.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

3.  The Clavien-Dindo classification of surgical complications: five-year experience.

Authors:  Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

4.  Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.

Authors:  Dipen J Parekh; Isildinha M Reis; Erik P Castle; Mark L Gonzalgo; Michael E Woods; Robert S Svatek; Alon Z Weizer; Badrinath R Konety; Mathew Tollefson; Tracey L Krupski; Norm D Smith; Ahmad Shabsigh; Daniel A Barocas; Marcus L Quek; Atreya Dash; Adam S Kibel; Lynn Shemanski; Raj S Pruthi; Jeffrey Scott Montgomery; Christopher J Weight; David S Sharp; Sam S Chang; Michael S Cookson; Gopal N Gupta; Alex Gorbonos; Edward M Uchio; Eila Skinner; Vivek Venkatramani; Nachiketh Soodana-Prakash; Kerri Kendrick; Joseph A Smith; Ian M Thompson
Journal:  Lancet       Date:  2018-06-23       Impact factor: 79.321

5.  Interpreting the significance of changes in health-related quality-of-life scores.

Authors:  D Osoba; G Rodrigues; J Myles; B Zee; J Pater
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Open vs robot-assisted radical cystectomy (BORARC): a double-blinded, randomised feasibility study.

Authors:  Sophia L Maibom; Martin A Røder; Eske K Aasvang; Malene Rohrsted; Peter O Thind; Per Bagi; Thomas Kistorp; Alicia M Poulsen; Lisbeth N Salling; Henrik Kehlet; Klaus Brasso; Ulla N Joensen
Journal:  BJU Int       Date:  2021-11-09       Impact factor: 5.969

7.  Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.

Authors:  Bernard H Bochner; Guido Dalbagni; Daniel D Sjoberg; Jonathan Silberstein; Gal E Keren Paz; S Machele Donat; Jonathan A Coleman; Sheila Mathew; Andrew Vickers; Geoffrey C Schnorr; Michael A Feuerstein; Bruce Rapkin; Raul O Parra; Harry W Herr; Vincent P Laudone
Journal:  Eur Urol       Date:  2014-12-08       Impact factor: 20.096

Review 8.  Enhanced Recovery Pathways Versus Standard Care After Cystectomy: A Meta-analysis of the Effect on Perioperative Outcomes.

Authors:  Mark D Tyson; Sam S Chang
Journal:  Eur Urol       Date:  2016-06-11       Impact factor: 20.096

9.  A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).

Authors:  Muhammad Shamim Khan; Christine Gan; Kamran Ahmed; Ahmad Fahim Ismail; Jane Watkins; Jennifer A Summers; Janet L Peacock; Peter Rimington; Prokar Dasgupta
Journal:  Eur Urol       Date:  2015-08-10       Impact factor: 20.096

10.  Robotic versus open radical cystectomy for bladder cancer in adults.

Authors:  Bhavan Prasad Rai; Jasper Bondad; Nikhil Vasdev; Jim Adshead; Tim Lane; Kamran Ahmed; Mohammed S Khan; Prokar Dasgupta; Khurshid Guru; Piotr L Chlosta; Omar M Aboumarzouk
Journal:  Cochrane Database Syst Rev       Date:  2019-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.